Skip to main content

News

September 23, 2020
Study by Breast Cancer Surgeons at University of Texas Southwestern Medical Center Published in the Annals of Surgical Oncology
September 16, 2020
Treatment with olvimulogene nanivacirepvec (Olvi-Vec)-primed immunochemotherapy shows promising overall survival benefit in this heavily pretreated late-stage patient population
September 10, 2020
Adaptive therapy provides the ability to personalize patient treatment at the time of treatment based on patient's anatomy and precise position
September 09, 2020
New study suggests that high-intensity focused ultrasound ablation is effective against prostate cancer with decreased side effects and improved recovery time. LOS ANGELES, Sept. 8, 2020 — For some prostate cancer patients, radical treatment (…
September 09, 2020
CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for GAVRETO
September 03, 2020
SUZHOU, China, Sept. 3, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966 HK) announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to KN046, a recombinant humanized PD-L1/CTLA-4…
September 03, 2020
LLS partners with PRA to help manage industry-first LLS PedAL master clinical trial to address the urgent need for new treatments for pediatric acute leukemia
August 24, 2020
Five-year collaboration culminates in database of 1,650 enrolled patients to characterize the safety, effectiveness and impact regarding the real-world utilization of SIR-Spheres® microspheres.
August 13, 2020
Brings Benefits of MRI-Guided Radiation Therapy Closer to Home for Cancer Patients in New England
August 07, 2020
Announcing CIOctober, an online experience providing practical interventional oncology education every Tuesday this October. Register today!
August 06, 2020
Sirtex announces the launch of SIROS™, an innovative system for the delivery of SIR-Spheres® Y-90 resin microspheres.
Back to Top